Abstract | INTRODUCTION: The impact on clinical outcomes of the metal coverage on the coronary surface (namely the metal-to-artery ratio) of currently used drug-eluting stents (DESs) has not been defined. METHODS: All patients with a left main or bifurcation stenosis treated with percutaneous coronary intervention (PCI) using ultrathin stents (struts thinner than 81 μm) were enrolled with a prospective multicentre fashion. The rate of device-oriented endpoint [DOE, defined as a composite of target lesion revascularization (TLR) and stent thrombosis] was the primary endpoint, while its single components were the secondary ones, evaluated according to the metal-to-artery ratio. RESULTS: After 14 ± 10.4 months 62 (7.5%) of 830 patients undergoing PCI on left main experienced a DOE without differences in the metal-to-artery ratio (14.5 ± 2.1 vs. 14.4 ± 1.9, P = 0.51). Fifty out (2.4%) of 2082 patients treated with PCI on a coronary bifurcation other than left main experienced a DOE, with a higher mean metal-to-artery ratio (15.3 ± 2.1 vs. 14.6 ± 2, P = 0.01). At multivariate analysis, together with hypertension and diabetes, the metal-to-artery ratio was an independent predictor of DOE (hazard ratio 1.7 : 1.02-1.34, P = 0.02) in nonleft main PCI. When analysed for diameter, we found a significant correlation with DOE when the stent diameter was inferior to 3.0 mm (hazard ratio 1.21: 1.06-1.38, P < 0.01, all 95% confidence interval); this result was mainly consistent for patients treated with provisional stenting. The metal-to-artery ratio does not impact on outcomes in left main PCI, both in the provisional or two- stent technique, and generally when a drug-eluting stent more than 3.5 mm in diameter is implanted. Regarding nonleft main PCI, it is independently related to DOE and TLR, especially for DES with a diameter of 3.25 mm or less. CONCLUSION: The metal-to-artery ratio does not impact on outcomes in left main PCI, both in the provisional or two- stent technique, and generally when a drug-eluting stent more than 3.5 mm in diameter is implanted. Regarding nonleft main PCI, it is independently related to DOE and TLR, especially for DES with a diameter of 3.25 mm or less.
|
Authors | Mario Iannaccone, Fabrizio D'Ascenzo, Paolo Gatti, Enrico Cerrato, Ivan Nuñez-Gil, Wojciech Wojakowski, Davide Capodanno, Filippo Figini, Wojciech Wańha, Alaide Chieffo, Gaetano Maria De Ferrari, Carlo Di Mario |
Journal | Journal of cardiovascular medicine (Hagerstown, Md.)
(J Cardiovasc Med (Hagerstown))
Vol. 21
Issue 9
Pg. 669-674
(Sep 2020)
ISSN: 1558-2035 [Electronic] United States |
PMID | 32639328
(Publication Type: Journal Article, Multicenter Study)
|
Chemical References |
|
Topics |
- Aged
- Aged, 80 and over
- Coronary Artery Disease
(diagnostic imaging, therapy)
- Coronary Thrombosis
(etiology)
- Drug-Eluting Stents
- Europe
- Female
- Humans
- Male
- Metals
- Middle Aged
- Percutaneous Coronary Intervention
(adverse effects, instrumentation)
- Prospective Studies
- Prosthesis Design
- Risk Assessment
- Risk Factors
- Time Factors
- Treatment Outcome
|